|
|
市场分析报告
|
Theratechnologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Massachusetts General Hospital (USA) to evaluate tesamorelin in relative growth hormone deficient abdominally ...
HIV associated Lipodystrophy - Pipeline Review - 2019 ... ALRN-5281 Leptin Necasermin Somatropin Tesamorelin acetate
Lipodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major lipodystrophy markets are expected to exhibit a CAGR of 4.45% during 2024-2034. The lipodystrophy market has been comprehensively analyzed in IMARC's new report titled "Lipodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, ...
Theratechnologies Inc (TH) - Financial and Strategic SWOT Analysis Review ... company’s marketed products include Egrifta (tesamorelin for injection) and Egrifta SV is indicated ...
|
|
|
|